FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog Is BPC 157 Banned? Oral vs. Injectable Forms Explained FDA Peptide Reclassification 2026: What It Means for Providers BPC 157 What Athletes Need to Know About Legality, Safety and Efficacy Training & Conditioning The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion